Clinical outcomes of drug-eluting balloon for treatment of small coronary artery in patients with acute myocardial infarction

Qiang Tan1, Qingsheng Wang2, Hongmei Yang2, Jing Zhang2, Ming Chen2
1Department of Cardiology, Qinhuangdao First Hospital, Hebei Medical University, Qinhuangdao, China
2Department of Cardiology, Qinhuangdao First Hospital, Hebei Medical University, No. 258 of Wenhua Road, Qinhuangdao, 066000, Hebei Province, China.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ismail MD, Ahmad WAW, Leschke M, Waliszewski M, Boxberger M, Abidin IZ et al (2016) The outcomes of patients with very small coronary artery disease treated with thin strut cobalt chromium bare metal stents: an observational study. Springerplus 5(1):1668

Mohiaddin H, Wong TD, Burke-Gaffney A, Bogle RG (2018) Drug-coated balloon-only percutaneous coronary intervention for the treatment of de novo coronary artery disease: a systematic review. Cardiol Ther 7:127–149

Worthley S, Hendriks R, Worthley M, Whelan A, Walters D, Whitbourn R et al (2015) Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study. Cardiovasc Revasc Med 16:413–417

Besic KM, Strozzi M, Margetic E, Bulum J, Kolaric B (2015) Drug-eluting balloons in patients with non-ST elevation acute coronary syndrome. J Cardiol 65:203–207

Baan J, Claessen BE, Dijk KB, Vendrik J, van der Schaaf RJ, Meuwissen M et al (2018) A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis. The DARE trial. J Am Coll Cardiol Interv 11:275–283

Kufner S, Cassese S, Valeskini M, Neumann F, Schulz-Schüpke S, Hoppmann P et al (2015) Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis 3-year results of a randomized controlled trial. J Am Coll Cardiol Interv 8:877–884

Alfonso F, Pérez-Vizcayno MJ, Cuesta J, del Blanco BG, García-Touchard A, López-Mínguez JR et al (2018) 3-Year clinical follow-up of the ribs iv clinical trial: a prospective randomized study of drug-eluting balloons versus everolimus eluting stents in patients with in-stent restenosis in coronary arteries previously treated with drug-eluting stents. J Am Coll Cardiol Interv 11:981–991

Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, Felice F et al (2012) A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels. The BELLO (Balloon Elution and Late Loss Optimization) study. JACC 60(24):2473–2480

Giannini F, Latib A, Jabbour RJ, Costopoulos C, Chieffo A, Carlino M et al (2017) Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients—results from the BELLO (balloon elution and late loss optimization) trial. Cardiovasc Revascul Med 18(1):4–9

Sinaga DA, Ho HH, Watson TJ, Sim A, Nyein TT, Jafary FH et al (2016) Drug-coated balloons: a safe and effective alternative to drug-eluting stents in small vessel coronary artery disease. J Interv Cardiol 29(5):454–460

Tan Q, Wang QS, Liu DT, Zhang SY, Zhang Y, Li Y (2015) Intravascular ultrasound-guided unprotected left main coronary artery stenting in the elderly. Saudi Med J 36(5):549–553

Picard F, Doucet S, Asgar AW (2017) Contemporary use of drug-coated balloons in coronary artery disease: where are we now? Arch Cardiovasc Dis 110(4):259–272

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al (2019) 2018 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention 14(14):1435–1534

Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S et al (2010) Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 96(16):1291–1296

Sim HW, Ananthakrishna R, Chan SP, Low AF, Lee CH, Chan MY et al (2018) Treatment of very small de novo coronary artery disease with 2.0 mm drug-coated balloons showed 1-year clinical outcome comparable with 2.0 mm drug-eluting stents. J Invasive Cardiol 30(7):256–261

Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Van Belle E et al (2012) First results of the DEBAMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicentre randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J Am Coll Cardiol 59:2327–2337

Fang CY, Fang HY, Chen CJ, Yang CH, Wu CJ, Lee WC (2018) Comparison of clinical outcomes after drug-eluting balloon and drugeluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study. PeerJ 15(6):e4646

Vos NS, Fagel ND, Amoroso G, Herrman JR, Patterson MS, Piers LH et al (2019) Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial. JACC Cardiovasc Interv 12(17):1691–1699